AccessPediatrics hosts the 2018 Immunization Schedule for Children and Adolescents that was just released and approved by the American Academy of Pediatrics (AAP), the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC), the American Academy of Family Physicians (AAFP), and the American College of Obstetricians and Gynecologists (ACOG).

Key changes include:

• Hepatitis B: Additional information regarding the timing of the birth dose for infants with a birth weight of <2000 g who are born to mothers who are negative for hepatitis B surface antigen has been added;

• H influenzae type b: MenHibrix (bivalent meningococcal conjugate vaccine and H influenzae type b conjugate vaccine) has been removed because the vaccine is no longer commercially available, and all remaining doses have expired;

• Influenza: Wording has been changed to indicate that live attenuated influenza vaccine is not recommended for the 2017–2018 influenza season;

• Meningococcal vaccines: Only quadrivalent meningococcal conjugate vaccines are discussed in footnote 11. Serogroup B meningococcal vaccines are discussed in a separate footnote (12);

• Polio vaccines: Updated wording provides guidance for children who have received oral polio vaccine as part of their series; and

Measles-mumps-rubella vaccines: Guidance is provided in regard to use of a third dose of a mumps-containing vaccine during a mumps outbreak.

Additional information can be found in the AAP’s policy statement at http://pediatrics.aappublications.org/content/early/2018/02/02/peds.2018-0083